secwatch.observer — SEC 8-K summary
======================================

Issuer:     RayzeBio, Inc. (—)
CIK:        0001825367
Form:       8-K
Filed at:   2023-09-19T23:59:59+00:00
Accession:  0001193125-23-237666
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RayzeBio closes upsized IPO of 19.87M shares at $18.00, raising ~$336.7M gross proceeds
--------------------------------------------------------------------------------

- Closed IPO of 19,869,240 shares at $18.00 per share, including full exercise of underwriters' option for 2,591,640 additional shares.
- Gross proceeds to RayzeBio of approximately $336.7 million before underwriting discounts and expenses.
- Selling stockholder sold 1,163,000 shares; RayzeBio received no proceeds from those sales.
- Shares began trading on Nasdaq Global Market on September 15, 2023 under ticker RYZB.
- Joint book-running managers: J.P. Morgan, Jefferies, Evercore ISI, Truist Securities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1825367/000119312523237666/0001193125-23-237666-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1825367/000119312523237666/d474188d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-237666

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer